These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 17659875)

  • 21. Cognitive impairment in multiple sclerosis.
    Hoffmann S; Tittgemeyer M; von Cramon DY
    Curr Opin Neurol; 2007 Jun; 20(3):275-80. PubMed ID: 17495620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cognitive functions in multiple sclerosis. Bibliographic review (1980-1991)].
    Vicens A; de Castro P
    Neurologia; 1992; 7(7):185-9. PubMed ID: 1419088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in cerebral activation patterns in idiopathic inflammatory demyelination using the paced visual serial addition task: an fMRI study.
    Rachbauer D; Kronbichler M; Ropele S; Enzinger C; Fazekas F
    J Neurol Sci; 2006 May; 244(1-2):11-6. PubMed ID: 16480742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuropsychological evaluation and psychopathology of multiple sclerosis].
    Defer G
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1128-34. PubMed ID: 11787345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuropsychological evaluation in multiple sclerosis].
    Arnett P; Forn C
    Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early cognitive impairment in multiple sclerosis predicts disability outcome several years later.
    Deloire M; Ruet A; Hamel D; Bonnet M; Brochet B
    Mult Scler; 2010 May; 16(5):581-7. PubMed ID: 20194578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thalamic atrophy and cognition in multiple sclerosis.
    Houtchens MK; Benedict RH; Killiany R; Sharma J; Jaisani Z; Singh B; Weinstock-Guttman B; Guttmann CR; Bakshi R
    Neurology; 2007 Sep; 69(12):1213-23. PubMed ID: 17875909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diffusion-weighted imaging predicts cognitive impairment in multiple sclerosis.
    Benedict RH; Bruce J; Dwyer MG; Weinstock-Guttman B; Tjoa C; Tavazzi E; Munschauer FE; Zivadinov R
    Mult Scler; 2007 Jul; 13(6):722-30. PubMed ID: 17613599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive impairment and structural brain damage in benign multiple sclerosis.
    Rovaris M; Riccitelli G; Judica E; Possa F; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Mattioli F; Martinelli V; Comi G; Filippi M
    Neurology; 2008 Nov; 71(19):1521-6. PubMed ID: 18815387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients.
    Yozbatiran N; Baskurt F; Baskurt Z; Ozakbas S; Idiman E
    J Neurol Sci; 2006 Jul; 246(1-2):117-22. PubMed ID: 16678208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Working memory and processing speed deficits in systemic lupus erythematosus as measured by the paced auditory serial addition test.
    Shucard JL; Parrish J; Shucard DW; McCabe DC; Benedict RH; Ambrus J
    J Int Neuropsychol Soc; 2004 Jan; 10(1):35-45. PubMed ID: 14751005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between cognitive deficits and everyday functional activities in multiple sclerosis.
    Kalmar JH; Gaudino EA; Moore NB; Halper J; Deluca J
    Neuropsychology; 2008 Jul; 22(4):442-9. PubMed ID: 18590356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Siracusa G; Sorbi S; Amato MP
    Clin Neuropsychol; 2009 Feb; 23(2):268-75. PubMed ID: 18609336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Executive dysfunction and cognitive impairment in a large community-based sample with Multiple Sclerosis from New Zealand: a descriptive study.
    Drew M; Tippett LJ; Starkey NJ; Isler RB
    Arch Clin Neuropsychol; 2008 Jan; 23(1):1-19. PubMed ID: 17981008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.
    Morrow SA; O'Connor PW; Polman CH; Goodman AD; Kappos L; Lublin FD; Rudick RA; Jurgensen S; Paes D; Forrestal F; Benedict RH
    Mult Scler; 2010 Nov; 16(11):1385-92. PubMed ID: 20739335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimal neuropsychological assessment of MS patients: a consensus approach.
    Benedict RH; Fischer JS; Archibald CJ; Arnett PA; Beatty WW; Bobholz J; Chelune GJ; Fisk JD; Langdon DW; Caruso L; Foley F; LaRocca NG; Vowels L; Weinstein A; DeLuca J; Rao SM; Munschauer F
    Clin Neuropsychol; 2002 Aug; 16(3):381-97. PubMed ID: 12607150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue.
    Huolman S; Hämäläinen P; Vorobyev V; Ruutiainen J; Parkkola R; Laine T; Hämäläinen H
    Mult Scler; 2011 Nov; 17(11):1351-61. PubMed ID: 21846692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis.
    Sumowski JF; Chiaravalloti N; Wylie G; Deluca J
    J Int Neuropsychol Soc; 2009 Jul; 15(4):606-12. PubMed ID: 19573279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.